PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9383417-3	1995	Rapamycin, ascomycin and FK506 have a common domain responsible for binding to FKBP12, their cellular receptor, and different effector domains that determine the target of the complex.	Tacrolimus	25-30	FKBP prolyl isomerase 1A pseudogene 1	Homo sapiens	79-85	
9383417-7	1995	CONCLUSIONS: The designed rapamycin-based FKBP12 ligand exhibits powerful binding properties but, unlike rapamycin, shows no activity in IL-6 dependent B-cell proliferation and, in contrast to FK506, shows no activity in the IL-2 reporter assay.	Tacrolimus	193-198	FKBP prolyl isomerase 1A pseudogene 1	Homo sapiens	42-48